Ondansetron HCL 4 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FAXRX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,265
Award facts
- Contract value 100% obligated
- $18,265.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $18,265.15 delivery order to Amerisourcebergen Drug Corp on March 31, 2026, for Ondansetron HCL 4mg tablets (30-count).
The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 1, 2026, and carries firm fixed pricing with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FAXRX?
SPE2DR26FAXRX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 31, 2026.
How much is contract SPE2DR26FAXRX worth?
The government has obligated $18,265 on SPE2DR26FAXRX.
Is contract SPE2DR26FAXRX an order under another contract?
Yes. SPE2DR26FAXRX is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAXRX competed?
The extent of competition for SPE2DR26FAXRX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award